We remain convinced that antilymphocyte globulin (ALG) is a potent immunosuppressive agent in humans. For that reason, we have used it in essentially every case of renal transplantion since May of 1966; now, however, we are about to embark on a controlled clinical trial of ALG in kidney transplantation and await with tremendous interest the results of other such trials from other centres around the world.
|Original language||English (US)|
|Number of pages||5|
|Journal||Postgraduate Medical Journal|
|State||Published - 1976|
ASJC Scopus subject areas